International Journal Of Drug Regulatory Affairs
  • Year: 2024
  • Volume: 12
  • Issue: 4

FDA 510(k) submission insights for syringes

  • Author:
  • Akash Sharma1, Chandra Prakash2, Ankur Vora3, Harsh Mehta4
  • Total Page Count: 14
  • Page Number: 1 to 14

1Head of Regulatory Affairs, Revital Healthcare (EPZ) Limited, Kenya

2Head of Quality Assurance, Revital Healthcare (EPZ) Limited, Kenya

3Operations Director, Revital Healthcare (EPZ) Limited, Kenya

4International Sales Director, Revital Healthcare (EPZ) Limited, Kenya

Online published on 8 July, 2025.

Abstract

The FDA 510(k) premarket notification process is critical for obtaining market clearance for syringes, including both conventional and Auto Disable (AD) models. This paper provides a comprehensive review of the FDA 510(k) submission requirements for syringes, focusing on the relevant ISO and ASTM standards that govern performance, safety, and biocompatibility. It examines the specific standards applicable to sterile hypodermic syringes, such as ISO 7886-1:2017, 7886-2:2020, ISO 7886-3:2017 and ISO 7886-4:2018, as well as the requirements for sterilization and packaging as outlined by ASTM standards. Additionally, the paper discusses the testing and validation protocols necessary for demonstrating substantial equivalence to predicate devices and addresses challenges and strategies for successful submission. By offering detailed insights into regulatory requirements and compliance strategies, this paper aims to guide manufacturers through the FDA 510(k) process for syringes, ensuring adherence to established standards and facilitating market approval.

Keywords

FDA 510(k), Syringes, ISO Standards, Auto Disable Syringes, ASTM standards